Cyclerion Therapeutics (CYCN)
Holds a suspended depression-treatment system and out-licensed sGC development rights.
$23.52
vs last close0.00 (0.00%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 49 days
EPS estimate
−$50.40
Revenue estimate
$550.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.22−$0.56−$0.11−$0.30−$1.75−$2.66−$0.41Pending
Estimate———−$121.80−$2.66−$2.66−$7.10−$50.40
Surprise———+99.8%+34.2%0.0%+94.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.8M$81.0K$93.0K$875.0K$1.0M$100.0K—Pending
Estimate———$100.0K$100.0K$100.0K$1.5M$550.0K
Surprise———+775.0%+925.0%0.0%——
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2029 | −$0.38 | — | — |
| Jun 2029 | −$7.40 | — | — |
| Mar 2029 | −$6.40 | — | — |
| Dec 2028 | −$5.60 | — | — |
| Sep 2028 | −$6.00 | — | — |
| Jun 2028 | −$5.80 | — | — |
| Mar 2028 | −$6.20 | — | — |
| Dec 2027 | −$6.00 | — | — |
| Sep 2027 | −$7.20 | — | — |
| Jun 2027 | −$6.00 | — | — |
| Mar 2027 | −$7.10 | — | — |
| Dec 2026 | −$7.20 | — | — |
| Nov 2026 | −$50.40 | — | — |
| Aug 2026 | −$7.10 | −$0.41 | +94.2% |
| May 2026 | −$2.66 | −$2.66 | 0.0% |
| Mar 2026 | −$2.66 | −$1.75 | +34.2% |
| Nov 2025 | −$121.80 | −$0.30 | +99.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2029 | −$0.38 | — | — | $100.0K | — | — | — |
| Jun 2029 | −$7.40 | — | — | $100.0K | — | — | — |
| Mar 2029 | −$6.40 | — | — | $0 | — | — | — |
| Dec 2028 | −$5.60 | — | — | $100.0K | — | — | — |
| Sep 2028 | −$6.00 | — | — | $0 | — | — | — |
| Jun 2028 | −$5.80 | — | — | $153.0K | — | — | — |
| Mar 2028 | −$6.20 | — | — | $153.0K | — | — | — |
| Dec 2027 | −$6.00 | — | — | $355.5K | — | — | — |
| Sep 2027 | −$7.20 | — | — | $550.0K | — | — | — |
| Jun 2027 | −$6.00 | — | — | $900.0K | — | — | — |
| Mar 2027 | −$7.10 | — | — | $1.5M | — | — | — |
| Dec 2026 | −$7.20 | — | — | $550.0K | — | — | — |
| Nov 11, 2026 | −$50.40 | — | — | $550.0K | — | — | — |
| Aug 4, 2026 | −$7.10 | −$0.41 | +94.2% | $1.5M | — | — | +0.6% |
| May 5, 2026 | −$2.66 | −$2.66 | 0.0% | $100.0K | $100.0K | 0.0% | +2.9% |
| Mar 17, 2026 | −$2.66 | −$1.75 | +34.2% | $100.0K | $1.0M | +925.0% | −1.4% |
| Nov 12, 2025 | −$121.80 | −$0.30 | +99.8% | $100.0K | $875.0K | +775.0% | +1.4% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Jul 28, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Jul 29, 2021 | |||||||
| Apr 30, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 3, 2020 | |||||||
| May 4, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 13, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 |